• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

没有方法可以估计在激动剂亚饱和浓度下的最大 PA。

Null method to estimate the maximal PA at subsaturating concentrations of agonist.

机构信息

Department of Anesthesiology, Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine, St. Louis, MO, USA.

出版信息

J Gen Physiol. 2025 Jan 6;157(1). doi: 10.1085/jgp.202413644. Epub 2024 Nov 25.

DOI:10.1085/jgp.202413644
PMID:39585302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11602654/
Abstract

The maximal probability of being in an active state (PA,max) is a measure of gating efficacy for a given agonist acting on a given receptor channel. In macroscopic electrophysiological recordings, PA,max is typically estimated by comparing the amplitude of the current response to a saturating concentration of a test agonist to that of a reference agonist with known PA. Here, we describe an approach to estimate the PA,max for low-efficacy agonists at subsaturating concentrations. In this approach, the amplitude of the response to a high-efficacy control agonist applied alone is compared with the amplitude of the response to a control agonist coapplied with the low-efficacy test agonist that binds to the same site(s). If the response to the combination is larger than the response to the control agonist alone, then the PA,max of the test agonist is greater than the PA of the control response. Conversely, if the response to the control agonist is reduced upon exposure to the test agonist, then the PA,max of the test agonist is smaller than the PA of the control response. The exact PA,max of the test agonist can be determined by testing its effect at different concentrations of the control agonist to estimate the PA at which the effect changes direction. The main advantage of this approach lies in the ability to use low, subsaturating concentrations of the test agonist. The model-based predictions are supported by observations from activation of heteromeric and homomeric GABAA receptors by combinations of high- and low-efficacy orthosteric agonists.

摘要

最大激活概率 (PA,max) 是衡量给定激动剂作用于特定受体通道的门控效率的指标。在宏观电生理学记录中,PA,max 通常通过比较测试激动剂的饱和浓度下的电流响应幅度与具有已知 PA 的参考激动剂的电流响应幅度来估计。在这里,我们描述了一种用于估计亚饱和浓度下低效能激动剂的 PA,max 的方法。在这种方法中,单独应用高效能对照激动剂的响应幅度与对照激动剂与结合到相同位点的低效能测试激动剂共同应用的响应幅度进行比较。如果组合的响应大于对照激动剂单独的响应,则测试激动剂的 PA,max 大于对照反应的 PA。相反,如果对照激动剂暴露于测试激动剂时响应降低,则测试激动剂的 PA,max 小于对照反应的 PA。可以通过测试测试激动剂在不同浓度的对照激动剂下的作用来确定其确切的 PA,max,以估计作用方向发生变化的 PA。这种方法的主要优点在于能够使用低浓度的亚饱和测试激动剂。该模型预测得到了由高和低效能的正位激动剂组合激活异源和同源 GABAA 受体的观察结果的支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f109/11602654/7ddf947d31d6/JGP_202413644_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f109/11602654/af5feb1aa4d7/JGP_202413644_Scheme1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f109/11602654/5cdc1e82d936/JGP_202413644_Scheme2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f109/11602654/950e7a0e74c4/JGP_202413644_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f109/11602654/948d914043f4/JGP_202413644_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f109/11602654/7ddf947d31d6/JGP_202413644_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f109/11602654/af5feb1aa4d7/JGP_202413644_Scheme1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f109/11602654/5cdc1e82d936/JGP_202413644_Scheme2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f109/11602654/950e7a0e74c4/JGP_202413644_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f109/11602654/948d914043f4/JGP_202413644_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f109/11602654/7ddf947d31d6/JGP_202413644_Fig3.jpg

相似文献

1
Null method to estimate the maximal PA at subsaturating concentrations of agonist.没有方法可以估计在激动剂亚饱和浓度下的最大 PA。
J Gen Physiol. 2025 Jan 6;157(1). doi: 10.1085/jgp.202413644. Epub 2024 Nov 25.
2
Loop G in the GABA receptor α1 subunit influences gating efficacy.γ-氨基丁酸(GABA)受体α1亚基中的G环影响门控效率。
J Physiol. 2017 Mar 1;595(5):1725-1741. doi: 10.1113/JP273752. Epub 2017 Jan 25.
3
Classic benzodiazepines modulate the open-close equilibrium in alpha1beta2gamma2L gamma-aminobutyric acid type A receptors.经典苯二氮䓬类药物调节α1β2γ2L型γ-氨基丁酸A型受体的开闭平衡。
Anesthesiology. 2005 Apr;102(4):783-92. doi: 10.1097/00000542-200504000-00014.
4
(+)- and (-)-cis-2-aminomethylcyclopropanecarboxylic acids show opposite pharmacology at recombinant rho(1) and rho(2) GABA(C) receptors.(+)-和(-)-顺式-2-氨甲基环丙烷羧酸在重组rho(1)和rho(2) GABA(C)受体上表现出相反的药理学特性。
J Neurochem. 2000 Dec;75(6):2602-10. doi: 10.1046/j.1471-4159.2000.0752602.x.
5
Activation of single heteromeric GABA(A) receptor ion channels by full and partial agonists.完全激动剂和部分激动剂对单个异聚体GABA(A)受体离子通道的激活作用
J Physiol. 2004 Jun 1;557(Pt 2):389-413. doi: 10.1113/jphysiol.2003.054734. Epub 2004 Feb 27.
6
An UNC-49 GABA receptor subunit from the parasitic nematode Haemonchus contortus is associated with enhanced GABA sensitivity in nematode heteromeric channels.寄生线虫旋毛虫 UNC-49 GABA 受体亚基与线虫异源通道中 GABA 敏感性的增强有关。
J Neurochem. 2010 Jun;113(5):1113-22. doi: 10.1111/j.1471-4159.2010.06651.x. Epub 2010 Feb 23.
7
Modulation of GABA(A) receptor channel gating by pentobarbital.戊巴比妥对GABA(A)受体通道门控的调节作用。
J Physiol. 2001 Dec 15;537(Pt 3):715-33. doi: 10.1111/j.1469-7793.2001.00715.x.
8
Reduced Activation of the Synaptic-Type GABA Receptor Following Prolonged Exposure to Low Concentrations of Agonists: Relationship between Tonic Activity and Desensitization.长期暴露于低浓度激动剂后突触型 GABA 受体的激活减少:紧张活动与脱敏之间的关系。
Mol Pharmacol. 2020 Dec;98(6):762-769. doi: 10.1124/molpharm.120.000088. Epub 2020 Sep 25.
9
Agonist-dependent single channel current and gating in alpha4beta2delta and alpha1beta2gamma2S GABAA receptors.α4β2δ和α1β2γ2S GABAA受体中激动剂依赖性单通道电流与门控
J Gen Physiol. 2008 Feb;131(2):163-81. doi: 10.1085/jgp.200709871.
10
The orthosteric GABAA receptor ligand Thio-4-PIOL displays distinctly different functional properties at synaptic and extrasynaptic receptors.正构GABAA受体配体硫代-4-皮考林醇在突触和突触外受体上表现出明显不同的功能特性。
Br J Pharmacol. 2013 Oct;170(4):919-32. doi: 10.1111/bph.12340.

本文引用的文献

1
How much does TRPV1 deviate from an ideal MWC-type protein?TRPV1与理想的MWC型蛋白有多大偏差?
Biophys J. 2024 Jul 16;123(14):2136-2144. doi: 10.1016/j.bpj.2024.04.005. Epub 2024 Apr 6.
2
Potentiation of the GABAR reveals variable energetic contributions by etiocholanolone and propofol.GABAR 的增效作用揭示了表雄酮和异丙酚的能量贡献具有可变性。
Biophys J. 2024 Jul 16;123(14):1954-1967. doi: 10.1016/j.bpj.2023.09.014. Epub 2023 Sep 26.
3
Differential assembly diversifies GABA receptor structures and signalling.差异组装使 GABA 受体结构和信号多样化。
Nature. 2022 Apr;604(7904):190-194. doi: 10.1038/s41586-022-04517-3. Epub 2022 Mar 30.
4
Steady-State Activation and Modulation of the Concatemeric 122L GABA Receptor.三聚体 122L GABA 受体的稳态激活和调节。
Mol Pharmacol. 2019 Sep;96(3):320-329. doi: 10.1124/mol.119.116913. Epub 2019 Jul 1.
5
Monod-Wyman-Changeux Allosteric Shift Analysis in Mutant 132L GABA Receptors Indicates Selectivity and Crosstalk among Intersubunit Transmembrane Anesthetic Sites.突变体 132L GABA 受体的 Monod-Wyman-Changeux 变构位移分析表明跨亚基跨膜麻醉位点的选择性和串扰。
Mol Pharmacol. 2019 Apr;95(4):408-417. doi: 10.1124/mol.118.115048. Epub 2019 Jan 29.
6
GABA receptor signalling mechanisms revealed by structural pharmacology.结构药理学揭示的 GABA 受体信号转导机制。
Nature. 2019 Jan;565(7740):454-459. doi: 10.1038/s41586-018-0832-5. Epub 2019 Jan 2.
7
Amino acid substitutions in the human homomeric β GABA receptor that enable activation by GABA.在人类同型 β GABA 受体中,氨基酸取代可使其被 GABA 激活。
J Biol Chem. 2019 Feb 15;294(7):2375-2385. doi: 10.1074/jbc.RA118.006229. Epub 2018 Dec 13.
8
Application of the Co-Agonist Concerted Transition Model to Analysis of GABAA Receptor Properties.共同激动协同转变模型在 GABA 受体性质分析中的应用。
Curr Neuropharmacol. 2019;17(9):843-851. doi: 10.2174/1570159X17666181206092418.
9
Analysis of GABA Receptor Activation by Combinations of Agonists Acting at the Same or Distinct Binding Sites.分析作用于相同或不同结合位点的激动剂组合对 GABA 受体的激活作用。
Mol Pharmacol. 2019 Jan;95(1):70-81. doi: 10.1124/mol.118.113464. Epub 2018 Oct 18.
10
Applying the Monod-Wyman-Changeux Allosteric Activation Model to Pseudo-Steady-State Responses from GABA Receptors.应用 Monod-Wyman-Changeux 变构激活模型分析 GABA 受体的拟稳态反应。
Mol Pharmacol. 2019 Jan;95(1):106-119. doi: 10.1124/mol.118.113787. Epub 2018 Oct 17.